Journal article

Characterization of Selenium Compounds for Anti-ferroptotic Activity in Neuronal Cells and After Cerebral Ischemia–Reperfusion Injury

QZ Tuo, S Masaldan, A Southon, C Mawal, S Ayton, AI Bush, P Lei, AA Belaidi

Neurotherapeutics | Published : 2021

Abstract

The emergence of ferroptosis as a cell death pathway associated with brain disorders including stroke and neurodegenerative diseases emphasizes the need to develop therapeutics able to target the brain and to protect neurons from ferroptotic death. Selenium plays an essential role in reducing lipid peroxidation generated during ferroptosis through its incorporation into the catalytic site of glutathione peroxidase 4. Here, we compared the anti-ferroptotic activity of several organic and inorganic selenium compounds: methylselenocysteine, selenocystine, selenomethionine, selenocystamine, ebselen, sodium selenite, and sodium selenate. All were effective against erastin- and RSL3-induced ferrop..

View full abstract

Grants

Awarded by Alzheimer's Association


Funding Acknowledgements

This study received funds from the Ministry of Science and Technology of China (2018YFC1312300), the National Natural Science Foundation of China (82071191, 81801182, 81722016), the National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University (Z2018B03), Sichuan University postdoctoral interdisciplinary Innovation Fund, the Post-Doctor Research Project, West China Hospital, Sichuan University (2018HXBH044), and the Alzheimer's Association (AARFD-16-442821).